Regional disparities in cost-effectiveness of biologics for CRSwNP should not modify the strategy
Rhinology Journal · 2025
DOI: 10.4193/rhin25.548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rhinology Journal, 2025. Verfasst von M Fieux und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d’ORL, d’otoneurochirurgie et de chirurgie cervico-faciale, Pierre Bénite, France;…. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Biological Products, Nasal Polyps.
Abstract (Originalsprache)
Chronic rhinosinusitis with nasal polyps (CRSwNP) represents a significant burden on the healthcare system (1). Xian et al. discussed several aspects of our economic model, based on French pricing, that may impact the cost-effectiveness of biologics (2). Briefly, they outlined the regional disparities in the cost of biologics, the potential better outcomes of biologics in real-world evidence, and the recurrence rate after endoscopic sinus surgery (ESS). We think that these aspects may be further discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d’ORL, d’otoneurochirurgie et de chirurgie cervico-faciale, Pierre Bénite, France;Université de Lyon, Université Lyon 1, Lyon, France;UMR 5305, Labora…
- Service ORL, Chirurgie Cervico-Maxillo-Faciale et Audiophonologie, Centre Hospitalier Universitaire de Poitiers, Poitiers, France;Laboratoire Inflammation Tissus Epithéliaux et Cytokines (LITEC), UR15560, Université d…
- Department of Otolaryngology - Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA, United States.
- Departement de ORL, chirurgie cervico faciale et maxillo-faciale, Hospital Gui de Chauliac, CHU de Montpellier, Montpellier, France;Research-team ICAR, Laboratory of Computer Science, Robotics and Microelectronics of Mo…
- Hospices Civils de Lyon, Pole de Sante Publique, Service d'Evaluation Economique en Sante, Research on Healthcare; Performance (RESHAPE), INSERM U1290, Universite Claude Bernard Lyon 1, Lyon, France.
Zitieren
APA
Fieux, M., Carsuzaa, F., Chang, M., Hwang, P. H., Patel, Z. M., Tringali, S., Favier, V., & Margier, J. (2025). Regional disparities in cost-effectiveness of biologics for CRSwNP should not modify the strategy. Rhinology Journal. https://doi.org/10.4193/rhin25.548
Vancouver
Fieux M, Carsuzaa F, Chang M, Hwang PH, Patel ZM, Tringali S, et al. Regional disparities in cost-effectiveness of biologics for CRSwNP should not modify the strategy. Rhinology Journal. 2025. doi:10.4193/rhin25.548
BibTeX
@article{Fieux2025,
author = {Fieux, M and Carsuzaa, F and Chang, M and Hwang, P H and Patel, Z M and Tringali, S and Favier, V and Margier, J},
title = {Regional disparities in cost-effectiveness of biologics for CRSwNP should not modify the strategy},
journal = {Rhinology Journal},
year = {2025},
doi = {10.4193/rhin25.548}
}
EUVIMED